The Actinobacillus pleuropneumoniae apxIV operon encodes an antibacterial toxin-immunity pair
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39740637
DOI
10.1016/j.micres.2024.128043
PII: S0944-5013(24)00444-0
Knihovny.cz E-zdroje
- Klíčová slova
- Actinobacillus pleuropneumoniae, Bacterial, Infectious Diseases, Pathogenesis, RTX proteins, Structural biology, Toxin-antitoxin system,
- MeSH
- Actinobacillus pleuropneumoniae * genetika patogenita imunologie metabolismus MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální proteiny * genetika chemie metabolismus imunologie MeSH
- bakteriální toxiny * genetika chemie metabolismus imunologie MeSH
- bakteriociny genetika MeSH
- faktory virulence genetika metabolismus MeSH
- infekce bakteriemi rodu Actinobacillus mikrobiologie veterinární MeSH
- operon * MeSH
- prasata MeSH
- virulence MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antibakteriální látky MeSH
- ApxIVA protein, Actinobacillus pleuropneumoniae MeSH Prohlížeč
- bakteriální proteiny * MeSH
- bakteriální toxiny * MeSH
- bakteriociny MeSH
- faktory virulence MeSH
The ApxIVA protein belongs to a distinct class of a "clip and link" activity of Repeat-in-ToXin (RTX) exoproteins. Along with the three other pore-forming RTX toxins (ApxI, ApxII and ApxIII), ApxIVA serves as a major virulence factor of Actinobacillus pleuropneumoniae, the causative agent of porcine pneumonia. The gene encoding ApxIVA is located on a bicistronic operon downstream of the orf1 gene and is expressed exclusively under in vivo conditions. Both ApxIVA and ORF1 are essential for full virulence of A. pleuropneumoniae, but the molecular mechanisms by which they contribute to the pathogenicity are not yet understood. Here, we provide a comprehensive structural and functional analysis of ApxIVA and ORF1 proteins. Our findings reveal that the N-terminal segment of ApxIVA shares structural similarity with colicin M (ColM)-like bacteriocins and exhibits an antimicrobial activity. The ORF1 protein resembles the colicin M immunity protein (Cmi) and, like Cmi, is exported to the periplasm through its N-terminal signal peptide. Additionally, ORF1 can protect bacterial cells from the antimicrobial activity of ApxIVA, suggesting that ORF1 and ApxIVA function as an antibacterial toxin-immunity pair. Moreover, we demonstrate that fetal bovine serum could elicit ApxIVA and ORF1 production under in vitro conditions. These findings highlight the coordinated action of various RTX determinants, where the fine-tuned spatiotemporal production of ApxIVA may enhance the fitness of A. pleuropneumoniae, facilitating its invasion to a resident microbial community on the surface of airway mucosa.
Citace poskytuje Crossref.org